Universe Pharmaceuticals (UPC) Price to Book (2021 - 2026)

Universe Pharmaceuticals has disclosed Price to Book across 6 years of filings, most recently posting 0.0 for Q1 2026.

• In Q1 2026, Price to Book fell 100.0% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 100.0% YoY), while the FY2025 annual figure was 0.0, down 100.0% from the prior year.
• Price to Book came in at 0.0 for Q1 2026 at Universe Pharmaceuticals, down from 0.0 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 18.0 in Q1 2022 to a low of 0.0 in Q1 2026.
• Average Price to Book over 5 years is 3.28, with a median of 0.01 recorded in 2022.
• The largest YoY upside for Price to Book was 151115.41% in 2025 against a maximum downside of 100.0% in 2025.
• Over 5 years, Price to Book stood at 0.01 in 2022, then tumbled by 64.4% to 0.0 in 2023, then surged by 15687.8% to 0.78 in 2024, then slumped by 100.0% to 0.0 in 2025, then sank by 33.95% to 0.0 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 0.0 in Q1 2026, 0.0 in Q3 2025, and 0.02 in Q1 2025.